Salvage RT After Prostatectomy Prevails in Long-Term Comparison With Adjuvant RT
No difference in freedom from distant metastasis or overall survival at 10 years
Stay updated with breaking news from Amaru Kishan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
No difference in freedom from distant metastasis or overall survival at 10 years
Although MRI detects radiorecurrent cancer overall, it may not accurately locate all lesions in the prostate gland. Investigators studied the role of MRI for detecting radiorecurrent prostate cancer for salvage focal therapy.
Study findings suggest that barriers exist in equitable administration of novel hormone therapy. Underuse of novel hormonal therapy agents in Black men with advanced prostate cancer continues and may be detrimental to their health.
The phase 3 PACE-B trial demonstrated that stereotactic body radiation therapy is noninferior to conventional radiation therapy for low- and favorable-intermediate-risk prostate cancer with respect to biochemical clinical failure. Stereotactic body radiation therapy is noninferior to conventional external beam radiation therapy for low- and favorable-intermediate-risk prostate cancer.
Identifying surrogate endpoints for use in clinical trials that strongly predict clinical outcomes such as improved survival and quality of life is challenging.